Optovue
22
0
0
19
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
9.1%
2 terminated/withdrawn out of 22 trials
90.5%
+4.0% vs industry average
5%
1 trials in Phase 3/4
16%
3 of 19 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (22)
SD-OCT Angiography
Role: collaborator
Performance Evaluation of OCT and OCT Angiography-based Ocular Measurements (Optical Coherence Tomography)
Role: lead
Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study
Role: collaborator
Data Collection of OCT and OCTA-based Ocular Measurements
Role: lead
Precision of OCT and OCTA-based Ocular Measurements
Role: lead
Comparison of OCT and OCTA-based Ocular Measurements to Those of Predicate
Role: lead
Prevalence of Vitreomacular Adhesion in Patients 40 Years and Older
Role: collaborator
OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits
Role: collaborator
Clinical Validation Study for iVue
Role: lead
Evaluation of the Repeatability and Reproducibility of AngioVue
Role: lead
Using the Optovue OCT to Select IOL Power
Role: collaborator
Evaluation of the Repeatability and Reproducibility of Corneal Epithelial Thickness Mapping With iVue SD-OCT
Role: lead
Evaluation of the Accuracy of Corneal Epithelial Thickness Mapping With SD-OCT
Role: lead
Evaluation of the Repeatability and Reproducibility of Corneal Epithelial Thickness Mapping With SD-OCT
Role: lead
Evaluation of RTVue XR With SSADA
Role: lead
Detection of Disease-Related Changes in Pre-Symptomatic Alzheimer's Disease
Role: collaborator
Evaluation of Corneal Epithelial Thickness Mapping
Role: lead
Evaluation of OCT Measurements
Role: lead
iCam Clinical Validation Study
Role: lead
Optical Coherence Tomography (OCT) Data Collection Study
Role: lead